High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansions: implications for pathogenesis of fat redistribution

被引:22
作者
Fessel, WJ [1 ]
Follansbee, SE [1 ]
Rego, J [1 ]
机构
[1] Kaiser Permanente Med Care Program, San Francisco, CA 94115 USA
关键词
HIV; lipodystrophy; fat expansion; HDL cholesterol; niacin; growth hormone;
D O I
10.1097/00002030-200209060-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To demonstrate relationships between plasma high-density lipoprotein (HDL) cholesterol and fat expansions in the fat redistribution syndrome. Design: Patients who had significant buffalo humps or intra-abdominal fat (IAF) expansions were identified and their HDL levels were measured. Control patients were all those undergoing a single trial of antiretroviral treatment. Some patients answered a self-administered questionnaire concerning self-perceived fat expansions, and their responses were related to their HDL levels. In other patients, relationships were studied between IAF measured by cross-section computerized tomography scans and HDL levels. Finally, patients who had IAF > 70 cm(2), were administered niacin, 3000 mg/day for greater than or equal to 6 months, in order to test whether raising HDL induced a decrease in IAF. Results: Twenty-three patients with buffalo humps had mean HDL of 30.4 mg/dl; 47 HIV-positive controls had mean HDL of 41.9 mg/dl (P=0.001). In 27 patients, IAF area and HDL were negatively correlated (r, 0.40; P=0.04). Among these 27, the 17 patients with IAF area > 100 cm(2) had mean HDL of 35.3 mg/dl; the 10 patients with IAF area < 100 cm(2) had mean HDL of 51 mg/dl (P<0.05). The 2 4 patients who indicated in a questionnaire that they had self-perceived IAF expansion had a median HDL of 36.0 mg/dl; the 20 who indicated that they did not have IAF expansion had a median HDL of 44.5 mg/dl (P=0.06). IAF decreased by 26.9% in 13 (81%) of the 16 patients who took niacin for 1 year; and the decrease in IAF was associated with a significant (P=0.002) increase in HDL. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:1785 / 1789
页数:5
相关论文
共 20 条
[1]   Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].
Brinkman, K ;
Smeitink, JA ;
Romijn, JA ;
Reiss, P .
LANCET, 1999, 354 (9184) :1112-1115
[2]  
CARR A, 2002, 9 C RETR OPP INF SEA
[3]   Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure [J].
Johannsson, G ;
Marin, P ;
Lonn, L ;
Ottosson, M ;
Stenlof, K ;
Bjorntorp, P ;
Sjostrom, L ;
Bengtsson, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) :727-734
[4]   Discontinuation of growth hormone (GH) treatment:: Metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects [J].
Johannsson, G ;
Albertsson-Wikland, K ;
Bengtsson, BÅ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12) :4516-4524
[5]   Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy [J].
Kakuda, TN ;
Brundage, RC ;
Anderson, PL ;
Fletcher, CV .
AIDS, 1999, 13 (16) :2311-2312
[6]   Association of Acanthosis nigricans with risk of diabetes mellitus and hormonal disturbances in females [J].
Lestringant, GG ;
Bener, A ;
Frossard, P ;
Townsend, A .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 71 (03) :267-269
[7]   The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation [J].
Lo, JC ;
Mulligan, K ;
Noor, MA ;
Schwarz, JM ;
Halvorsen, RA ;
Grunfeld, C ;
Schambelan, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3480-3487
[8]   LOCALIZATION OF THE GROWTH-HORMONE RECEPTOR-BINDING PROTEIN IN SKIN [J].
LOBIE, PE ;
BREIPOHL, W ;
LINCOLN, DT ;
GARCIAARAGON, J ;
WATERS, MJ .
JOURNAL OF ENDOCRINOLOGY, 1990, 126 (03) :467-&
[9]   Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection [J].
Mallal, SA ;
John, M ;
Moore, CB ;
James, IR ;
McKinnon, EJ .
AIDS, 2000, 14 (10) :1309-1316
[10]  
*NIH, 1980, NIH PUBL